Company Name

Industry

Location

Revenue

Employees

CRISPR Therapeutics

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

GSAS Harvard Biotech Club

Biotechnology

United States, Massachusetts

$1B and Over

201-500

Flagship Pioneering

Biotechnology

United States, Massachusetts

$500M to $1B

201-500

Ironwood Pharmaceuticals

Biotechnology

United States, Massachusetts

$250M to $500M

201-500

Agenus

Biotechnology

United States, Massachusetts

$250M to $500M

201-500

ImmunoGen

Biotechnology

United States, Massachusetts

$250M to $500M

201-500

New England Biolabs

Biotechnology

United States, Massachusetts

$250M to $500M

201-500

Acceleron Pharma

Biotechnology

United States, Massachusetts

$250M to $500M

201-500

Quanterix

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

deCODE genetics

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

ElevateBio

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

Seven Bridges

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

Seres Therapeutics

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

Vericel® Corporation

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

EQRx

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

MassBiologics

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

Fortis Life Sciences

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

Psychemedics Corporation

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

Associates of Cape Cod

Biotechnology

United States, Massachusetts

$100M to $250M

201-500

Pear Therapeutics

Biotechnology

United States, Massachusetts

$100M to $250M

201-500